ZYC101a for Treatment of High-Grade Cervical Intraepithelial Neoplasia-Reference-Cited by-同舟云学术

ZYC101a for Treatment of High-Grade Cervical Intraepithelial Neoplasia

Published:2004-02 Issue:2 Volume:103 Page:317-326
ISSN:0029-7844
Container-title:Obstetrics & Gynecology
language:en
Short-container-title:Obstetrics & Gynecology

Author:

Garcia Francisco,Petry Karl Ulrich,Muderspach Laila,Gold Michael A.,Braly Patricia,Crum Christopher P.,Magill Marianne,Silverman Michael,Urban Robert G.,Hedley Mary Lynne,Beach Kathleen J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynaecology

Reference30 articles.

1. Cancer Statistics, 2003

2. Impact of the bethesda system

3. Quality Management in Gynecologic Cytology Using Interlaboratory Comparison

4. Estimates of the worldwide mortality from 25 cancers in 1990

5. The Case for Cytologic Follow-up After LEEP

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, Efficacy, and Immunogenicity of Therapeutic Vaccines for Patients with High-Grade Cervical Intraepithelial Neoplasia (CIN 2/3) Associated with Human Papillomavirus: A Systematic Review;Cancers;2024-02-05

2. Immunotherapy that leverages HPV-specific immune responses for precancer lesions of cervical cancer;Taiwanese Journal of Obstetrics and Gynecology;2024-01

3. Efficacy and safety of therapeutic HPV vaccines to treat CIN 2/CIN 3 lesions: a systematic review and meta-analysis of phase II/III clinical trials;BMJ Open;2023-10

4. Emerging Treatment Options for Cervical Dysplasia and Early Cervical Cancer;Clinical Obstetrics & Gynecology;2023-07-25

5. Polymeric nanoparticles for DNA vaccine-based cancer immunotherapy: a review;Biotechnology Letters;2023-06-19